Pathway analysis of cancer-associated microRNA targets

被引:10
作者
Yang, Hao [1 ]
Zhang, Haiyang [1 ]
Zhu, Lin [2 ]
Wang, Jin [1 ]
Zhang, Chenyu [1 ]
Li, Donghai [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China
[2] Jiangsu Simcere Pharmaceut R&D Co Ltd, Inst Discovery Biol, Nanjing 210042, Jiangsu, Peoples R China
基金
中国国家自然科学基金; 高等学校博士学科点专项科研基金;
关键词
cancer; microRNA; pathway; tumor suppressor; oncogene; DOWN-REGULATION; CELL-MIGRATION; HTLV-I; EXPRESSION; CLUSTER; GENES; MIR-141; MIR-34A; PROTEIN; MIRNAS;
D O I
10.3892/ijo.2012.1658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinogenesis is a multi-step process, which includes oncogene activation, mutation silencing of tumor suppressor genes, impairment of chromosomes or epigenetic changes such as CpG island methylation through various cellular pathways, involving a series of somatic genetic alterations. Furthermore, miRNAs present a mechanism by which genes with diverse functions on multiple pathways can be simultaneously regulated at the post-transcriptional level. However, little is known about the cancer-related pathways through which cancer-associated miRNAs (CA-miRNAs) regulate these processes representing either positive or negative functions in carcinogenesis. This study investigated eleven miRNAs previously identified as cancer-related regulators. Using function and pathway analysis of their targeted genes, the relevance of miRNA regulation in the induction of cancer can be observed. The results showed that CA-miRNAs may function in the post-transcriptional level mainly through manipulating the expression of transcription factors and protein kinases, and target genes for the CA-miRNAs were most prominently predicted to function in the regulation of transcription. Our analysis also highlighted the potential of these CA-miRNAs to regulate the cell differentiation, proliferation, endocytosis and migration signaling logically required to cause a cancer cell mainly through five canonical pathways. Combined with previous cancer studies, the analysis of the relevance between functions of CA-miRNAs and cancer-related pathways exploring different internal carcinogenesis stimuli also revealed the potential of the top five pathways to regulate core carcinogenesis processes. These findings should form a useful knowledge base for potential future development of novel therapeutic treatments.
引用
收藏
页码:2213 / 2226
页数:14
相关论文
共 73 条
  • [1] miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
    Adam, Liana
    Zhong, Meng
    Choi, Woonyoung
    Qi, Wei
    Nicoloso, Milena
    Arora, Ameeta
    Calin, George
    Wang, Hua
    Siefker-Radtke, Arlene
    McConkey, David
    Bar-Eli, Menashe
    Dinney, Colin
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (16) : 5060 - 5072
  • [2] Involvement of MicroRNAs in Breast Cancer
    Adams, Brian D.
    Guttilla, Irene K.
    White, Bruce A.
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2008, 26 (06) : 522 - 536
  • [3] Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells
    Al-Nedawi, Khalid
    Meehan, Brian
    Micallef, Johann
    Lhotak, Vladimir
    May, Linda
    Guha, Abhijit
    Rak, Janusz
    [J]. NATURE CELL BIOLOGY, 2008, 10 (05) : 619 - U24
  • [4] Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition
    Bendoraite, Ausra
    Knouf, Emily C.
    Garg, Kavita S.
    Parkin, Rachael K.
    Kroh, Evan M.
    O'Briant, Kathy C.
    Ventura, Aviva P.
    Godwin, Andrew K.
    Karlan, Beth Y.
    Drescher, Charles W.
    Urban, Nicole
    Knudsen, Beatrice S.
    Tewari, Muneesh
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (01) : 117 - 125
  • [5] The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
    Bonci, Desiree
    Coppola, Valeria
    Musumeci, Maria
    Addario, Antonio
    Giuffrida, Raffaella
    Memeo, Lorenzo
    D'Urso, Leonardo
    Pagliuca, Alfredo
    Biffoni, Mauro
    Labbaye, Catherine
    Bartucci, Monica
    Muto, Giovanni
    Peschle, Cesare
    De Maria, Ruggero
    [J]. NATURE MEDICINE, 2008, 14 (11) : 1271 - 1277
  • [6] Pathophysiology of ageing, longevity and age related diseases
    Bürkle A.
    Caselli G.
    Franceschi C.
    Mariani E.
    Sansoni P.
    Santoni A.
    Vecchio G.
    Witkowski J.M.
    Caruso C.
    [J]. Immunity & Ageing, 4 (1)
  • [7] Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
    Calin, GA
    Dumitru, CD
    Shimizu, M
    Bichi, R
    Zupo, S
    Noch, E
    Aldler, H
    Rattan, S
    Keating, M
    Rai, K
    Rassenti, L
    Kipps, T
    Negrini, M
    Bullrich, F
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) : 15524 - 15529
  • [8] Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
    Calin, GA
    Sevignani, C
    Dan Dumitru, C
    Hyslop, T
    Noch, E
    Yendamuri, S
    Shimizu, M
    Rattan, S
    Bullrich, F
    Negrini, M
    Croce, CM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (09) : 2999 - 3004
  • [9] MiR-15a and miR-16-1 cluster functions in human leukemia
    Calin, George A.
    Cimmino, Amelia
    Fabbri, Muller
    Ferracin, Manuela
    Wojcik, Sylwia E.
    Shimizu, Masayoshi
    Taccioli, Cristian
    Zanesi, Nicola
    Garzon, Ramiro
    Aqeilan, Rami I.
    Alder, Hansjuerg
    Volinia, Stefano
    Rassenti, Laura
    Liu, Xiuping
    Liu, Chang-gong
    Kipps, Thomas J.
    Negrini, Massimo
    Croce, Carlo M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (13) : 5166 - 5171
  • [10] MicroRNA signatures in human cancers
    Calin, George A.
    Croce, Carlo M.
    [J]. NATURE REVIEWS CANCER, 2006, 6 (11) : 857 - 866